Omega-6 enriched pufa phospholipids

摘要

Pharmaceutical formulations comprise dihomo gamma linolenic acid (DGLA) or any appropriate metabolite or derivative e.g. 15-hydroxy-DGLA and krill oil (KO). They may be used for the treatment of a wide range of diseases and disorders. They may also be taken as a general nutritional supplement.